Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Gynecologic and Obstetric Investigation
|
January 1, 1995
Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement
E S Ginsburg, B W Walsh, B F Shea, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial
B W Walsh, S Paul, R A Wild, et al.
Circulation
|
September 22, 1998
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
M Gerhard, B W Walsh, A Tawakol, et al.
Annals of Internal Medicine
|
December 15, 1994
Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
E H Lieberman, M D Gerhard, A Uehata, et al.
JAMA
|
May 26, 1998
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
B W Walsh, L H Kuller, R A Wild, et al.
Thrombosis and Haemostasis
|
October 5, 1992
Coagulation activation following estrogen administration to postmenopausal women
Y G Caine, K A Bauer, S Barzegar, et al.
Heart (British Cardiac Society)
|
January 6, 1999
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia
O C Gebara, M A Mittleman, B W Walsh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial
R Lindsay, F Cosman, R A Lobo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
R W Downs, N H Bell, M P Ettinger, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Gynecologic and Obstetric Investigation
|
January 1, 1995
Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement
E S Ginsburg, B W Walsh, B F Shea, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial
B W Walsh, S Paul, R A Wild, et al.
Circulation
|
September 22, 1998
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
M Gerhard, B W Walsh, A Tawakol, et al.
Annals of Internal Medicine
|
December 15, 1994
Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
E H Lieberman, M D Gerhard, A Uehata, et al.
JAMA
|
May 26, 1998
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
B W Walsh, L H Kuller, R A Wild, et al.
Thrombosis and Haemostasis
|
October 5, 1992
Coagulation activation following estrogen administration to postmenopausal women
Y G Caine, K A Bauer, S Barzegar, et al.
Heart (British Cardiac Society)
|
January 6, 1999
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia
O C Gebara, M A Mittleman, B W Walsh, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial
R Lindsay, F Cosman, R A Lobo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
R W Downs, N H Bell, M P Ettinger, et al.
Page
of 4